tert-Butyl 4-(2-methoxy-2-oxoethylidene)-1-oxa-9-azaspiro[5.5]undecane-9-carboxylate

Catalog No. :
ACCETN729
CAS No. :
1356386-38-3
Molecular Formula :
C17H27NO5
Molecular Weight :
325.40

IUPAC Name:tert-butyl 4-(2-methoxy-2-oxoethylidene)-1-oxa-9-azaspiro[5.5]undecane-9-carboxylate

tert-Butyl 4-(2-methoxy-2-oxoethylidene)-1-oxa-9-azaspiro[5.5]undecane-9-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$365.00Login to see priceInquiryInquiry
1g98%$802.00Login to see priceInquiryInquiry
5g98%$2649.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(2-methoxy-2-oxoethylidene)-1-oxa-9-azaspiro[5.5]undecane-9-carboxylate
IUPAC Nametert-butyl 4-(2-methoxy-2-oxoethylidene)-1-oxa-9-azaspiro[5.5]undecane-9-carboxylate
MDL No.-
Molecular FormulaC17H27NO5
Molecular Weight325.40
SMILESO=C(OC)C=C1CCOC2(CCN(C(OC(C)(C)C)=O)CC2)C1
InChI KeyKSNOEDXEPSSKSJ-UHFFFAOYSA-N
Synonym1-Oxa-9-azaspiro[5.5]undecane-9-carboxylic acid, 4-(2-methoxy-2-oxoethylidene)-, 1,1-dimethylethyl ester;Methyl 2-(9-Boc-1-oxa-9-azaspiro[5.5]undecan-4-ylidene)acetate
CAS No.1356386-38-3

Synthetic Route by SureRoute

1. ACCETN729 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBDTX926 route compound structure diagram
    ACBDTX9261346229-51-3 In Stock
  2. Plus
  3. ACFUIK307 route compound structure diagram
    ACFUIK3071067-74-9 In Stock
  4. Then
  5. ACCETN729 route product structure diagram
    ACCETN7291356386-38-3
Inquiry

2. ACCETN729 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBDTX926 route compound structure diagram
    ACBDTX9261346229-51-3 In Stock
  2. Plus
  3. ACCSAO480 route compound structure diagram
    ACCSAO48021204-67-1 In Stock
  4. Then
  5. ACCETN729 route product structure diagram
    ACCETN7291356386-38-3
Inquiry

Comments (0)